Portfolio company
Bioarctic Biociences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops antibody-based disease-modifying treatments for neurodegenerative disorders, such as Alzheimer's and Parkinson's, for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for neurodegenerative disorders including Alzheimer's and Parkinson's diseases for healthcare providers and patients.
AC Immune
This biopharmaceutical company develops therapeutic and diagnostic candidates for neurodegenerative diseases, providing precision medicine solutions to patients, healthcare providers, and pharmaceutical partners.
Cerevance
This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.
Biogen Idec
This biotechnology company develops therapies for neurological, autoimmune, and hematological disorders for patients and healthcare professionals.
Alzeca Biosciences
This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.
Tetraneuron
This company develops gene therapies to treat Alzheimer's and other neurodegenerative diseases for healthcare providers and patients.
MindImmune
This pharmaceutical company develops immunomodulatory monoclonal antibodies to treat patients suffering from neurodegenerative diseases like Alzheimer's by targeting brain inflammation.
